ArticleTargeted oncology2025

Immunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase‑Positive Non‑small Cell Lung Cancer in Japan.

Yuki Shimomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.